Destination Wealth Management’s Boston Scientific BSX Stock Holding History

Destination Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,153	Closed	-$462K	–	148
2020 Q1	$462K	Buy	14,153 +1,211	+9%	+$47.3K	0.03%	126
2019 Q4	$585K	Buy	12,942 +68	+0.5%	+$2.85K	0.03%	111
2019 Q3	$524K	Sell	12,874 -114	-0.9%	-$4.83K	0.03%	110
2019 Q2	$558K	Buy	12,988 +114	+0.9%	+$4.38K	0.03%	109
2019 Q1	$494K	Hold	12,874	–	–	0.03%	113
2018 Q4	$455K	Hold	12,874	–	–	0.03%	113
2018 Q3	$496K	Sell	12,874 -1,000	-7%	-$34.9K	0.03%	117
2018 Q2	$454K	Buy	+13,874	New	+$418K	0.03%	112

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Destination Wealth Management's BSX Position: Q2 2020 in Review

Destination Wealth Management sold out of Boston Scientific (BSX) in Q2 2020, closing a stake of 14,153 shares — an estimated $462K sold.

Destination Wealth Management first reported a position in BSX in Q2 2018 and held it in 8 quarters. The position peaked at $585K in Q4 2019. 840 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

Destination Wealth Management reported no remaining Boston Scientific position as of Q2 2020 after selling out during the quarter.
Destination Wealth Management sold 14,153 Boston Scientific shares in Q2 2020, an estimated $462K.
Destination Wealth Management first reported a position in Boston Scientific in Q2 2018 and held it in 8 quarters.
Destination Wealth Management's Boston Scientific position peaked at $585K in Q4 2019.
840 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on Destination Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.